Phase 1 trial of everolimus plus sunitinib in patients with metastatic renal cell carcinoma
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Phase 1 trial of everolimus plus sunitinib in patients with metastatic renal cell carcinoma
Authors
Keywords
-
Journal
CANCER
Volume 118, Issue 7, Pages 1868-1876
Publisher
Wiley
Online
2011-09-07
DOI
10.1002/cncr.26429
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Non–Clear Cell Renal Cancer: Features and Medical Management
- (2017) Daniel Y. C. Heng et al. Journal of the National Comprehensive Cancer Network
- Combination targeted therapy in advanced renal cell carcinoma
- (2010) Jeffrey Sosman et al. CANCER
- Phase II Trial of Bevacizumab and Everolimus in Patients With Advanced Renal Cell Carcinoma
- (2010) John D. Hainsworth et al. JOURNAL OF CLINICAL ONCOLOGY
- Pazopanib in Locally Advanced or Metastatic Renal Cell Carcinoma: Results of a Randomized Phase III Trial
- (2010) Cora N. Sternberg et al. JOURNAL OF CLINICAL ONCOLOGY
- Everolimus (RAD001) in the Treatment of Advanced Renal Cell Carcinoma: A Review
- (2010) S. S. Agarwala et al. ONCOLOGIST
- Targeting mTOR in cancer: renal cell is just a beginning
- (2010) Hamdy Azim et al. Targeted Oncology
- Relationship between exposure to sunitinib and efficacy and tolerability endpoints in patients with cancer: results of a pharmacokinetic/pharmacodynamic meta-analysis
- (2009) Brett E. Houk et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- A Population Pharmacokinetic Meta-analysis of Sunitinib Malate (SU11248) and Its Primary Metabolite (SU12662) in Healthy Volunteers and Oncology Patients
- (2009) B. E. Houk et al. CLINICAL CANCER RESEARCH
- Phase I Study Combining Treatment with Temsirolimus and Sunitinib Malate in Patients with Advanced Renal Cell Carcinoma
- (2009) Premal H. Patel et al. Clinical Genitourinary Cancer
- Phase II Study of Sunitinib Administered in a Continuous Once-Daily Dosing Regimen in Patients With Cytokine-Refractory Metastatic Renal Cell Carcinoma
- (2009) Bernard Escudier et al. JOURNAL OF CLINICAL ONCOLOGY
- Effect of temsirolimus versus interferon-α on outcome of patients with advanced renal cell carcinoma of different tumor histologies
- (2009) Janice P. Dutcher et al. MEDICAL ONCOLOGY
- Combination Systemic Therapy for Advanced Renal Cell Carcinoma
- (2009) R. E. Miller et al. ONCOLOGIST
- Dose- and Schedule-Dependent Inhibition of the Mammalian Target of Rapamycin Pathway With Everolimus: A Phase I Tumor Pharmacodynamic Study in Patients With Advanced Solid Tumors
- (2008) Josep Tabernero et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase I Pharmacokinetic and Pharmacodynamic Study of the Oral Mammalian Target of Rapamycin Inhibitor Everolimus in Patients With Advanced Solid Tumors
- (2008) Anne O'Donnell et al. JOURNAL OF CLINICAL ONCOLOGY
- Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial
- (2008) Robert J Motzer et al. LANCET
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started